Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Chorus Aviation Inc T.CHR

Alternate Symbol(s):  CHRRF | T.CHR.DB.A | T.CHR.DB.B | T.CHR.DB.C

Chorus Aviation Inc. is a global aviation solutions provider and asset manager, focused on regional aviation. The Company’s primary business activities include contract flying, aircraft leasing, managing aircraft on behalf of fund investors and other third-party aircraft investors and/or owners, as well as maintenance, repair and overhaul services and pilot training. The Company operates through two segments: Regional Aviation Services and Regional Aircraft Leasing. Its subsidiaries include Falko Regional Aircraft, a pure play regional aircraft asset manager and lessor, and managing investments on behalf of third-party fund investors; Jazz Aviation, a regional airline in Canada and provider of regional air services under the Air Canada Express brand; Voyageur Aviation, a provider of specialty charter, aircraft modifications, parts provisioning and in-service support services, and Cygnet Aviation Academy, an accredited training academy preparing pilots for direct entry into airlines.


TSX:CHR - Post by User

Comment by givemeabreak1on Nov 16, 2020 11:00pm
207 Views
Post# 31912186

RE:Another vaccine works

RE:Another vaccine worksHerman
The type of Vaccine is just as important as the efficacy!  RNA is probably the best from a production standpoint!  Pfizer can produce about 1.2 billion doses next year.  Moderna about the same.  However, it will be at least another 6 months to get everyone in NA vaccinated... So likely air flight not back to normal until 2022.  So while I do not see any divy next year could have a nice price run.  Remember these vaccinations are based on 100 cases or less with Pfizer.  So the Moderna Vac had 100 cases 95 with Covid had the Placebo and only 5 with vaccination.  You still need more information that more cases will provide.  Info for example where did the 100 cases occurr were Placebo cases in areas of higher concentration.  Also, still no idea how long vac lasts.  Lots of hope so I can see it helping the stock price forward but divy will have to wait!
<< Previous
Bullboard Posts
Next >>